HDAC7: a promising target in cancer
Histones have a vital function as components of nucleosomes, which serve as the fundamental building blocks of chromatin. Histone deacetylases (HDACs), which target histones, suppress gene transcription by compacting chromatin. This implies that HDACs have a strong connection to the suppression of g...
Main Authors: | Cui Liu, Dan Zheng, Xuan Pu, Sijun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1327933/full |
Similar Items
-
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
by: Christian Mayr, et al.
Published: (2021-07-01) -
Pathological Role of HDAC8: Cancer and Beyond
by: Ji Yoon Kim, et al.
Published: (2022-10-01) -
HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights
by: Eugenia Passaro, et al.
Published: (2021-12-01) -
HDAC-an important target for improving tumor radiotherapy resistance
by: Rui Ling, et al.
Published: (2023-07-01) -
Natural Products Extracted from Fungal Species as New Potential Anti-Cancer Drugs: A Structure-Based Drug Repurposing Approach Targeting HDAC7
by: Annalisa Maruca, et al.
Published: (2020-11-01)